Search bioRxiv⌕ Search

bioRxiv · 10.1101/2025.11.20.681142

Cognitive Performance and Brain-Predicted Age Difference in Bipolar Disorder

Abstract

Neuroimaging-derived brain-predicted age difference (brain-PAD) is a promising marker of advanced brain aging, but its link to cognitive function in bipolar disorder (BD) is not well understood, especially when comparing across publicly available algorithms trained on diverse, large sample datasets and to algorithms trained on local cohorts with rich multimodal imaging data. Our study compares algorithms used to estimate brain-PAD in terms of their clinical relevance to cognition in BD. We included 44 euthymic BD I individuals and 73 HCs who completed the Delis-Kaplan Executive Function System, and we selected nine scores from this battery for further analyses. Raw scores were log-transformed, scaled, and subjected to PCA; PC1 indexed overall executive function. Four brain-PAD algorithms (PHOTON, BrainageR, DenseNet, Multimodal) were applied to T1-weighted MRI data; the multimodal algorithm also included Diffussion Tensor Imaging (DTI), Arterial Spin Labeling (ASL), functional Magnetic resonance imaging (fMRI) and resting state Magnetic resonance imaging (rsMRI) data. For each algorithm, we regressed brain-PAD on age, sex, and their interaction to obtain residuals, then used those residualized brain-PADs (which we refer to subsequently as brain-PADs throughout the text) to predict PC1. We then directly assessed if there were group differences in the relationship of brain-PAD to cognitive function by including an interaction term between group x brain-PAD. We found no significant group x brain-PAD interaction across all four algorithms. Given that, we then combined BD and HC and explored whether brain-PAD was a meaningful predictor of cognitive performance. Multimodal brain-PAD emerged as a strong negative predictor of cognitive performance (Beta Estimate = -0.084, SE = 0.024, t = -3.50, p < 0.001), indicating that those with older-appearing brains, as indexed by the brain-PAD, scored lower on PC1. BrainageR brain-PAD also significantly predicted PC1 (Beta Estimate = -0.031, SE = 0.0116, t = -2.71, p < 0.01), and DenseNet brain-PAD showed a modest effect (Beta Estimate = -0.0355, SE = 0.0177, t = -2.00, p < 0.05). PHOTON brain-PAD demonstrated a negative trend with PC1 (Beta Estimate = -0.024, SE = 0.0127, t = -1.92, p = 0.06). Residualized brain-PAD, after accounting for age and sex, was inversely associated with a composite metric of executive functioning, particularly for an algorithm integrating a range of imaging modalities. Our findings demonstrate how brain aging patterns captured by a neuroimaging-based, ML-derived composite metric could be associated with cognitive performance across algorithms trained on a variety of data granularity and sample sizes.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Ng, H. X., Sutherland, A., Eyler, L.. 2025-11-21. Cognitive Performance and Brain-Predicted Age Difference in Bipolar Disorder. https://doi.org/10.1101/2025.11.20.681142

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗